Black Rock Inc. Inmune Bio, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 812,895 shares of INMB stock, worth $3.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

812,895

Previous 240,166 238.47%

Holding current value

$3.65 Million

Previous $2.82 Million 154.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.15 - $11.84 $4.1 Million - $6.78 Million	572,729 Added 238.47%	812,895 $7.17 Million
Q1 2024 May 10, 2024	SELL	$10.53 - $14.01 $187,044 - $248,859	-17,763 Reduced 6.89%	240,166 $2.82 Million
Q4 2023 Feb 13, 2024	BUY	$6.6 - $11.52 $165,693 - $289,209	25,105 Added 10.78%	257,929 $2.9 Million
Q3 2023 Nov 13, 2023	SELL	$6.61 - $10.9 $45,007 - $74,218	-6,809 Reduced 2.84%	232,824 $1.58 Million
Q2 2023 Aug 11, 2023	BUY	$6.5 - $10.09 $31,908 - $49,531	4,909 Added 2.09%	239,633 $2.18 Million
Q1 2023 May 12, 2023	SELL	$6.01 - $10.18 $3,612 - $6,118	-601 Reduced 0.26%	234,724 $1.52 Million
Q4 2022 Feb 13, 2023	BUY	$6.13 - $7.96 $12,762 - $16,572	2,082 Added 0.89%	235,325 $1.49 Million
Q3 2022 Nov 14, 2022	SELL	$6.04 - $10.44 $5,297 - $9,155	-877 Reduced 0.37%	233,243 $1.45 Million
Q2 2022 Aug 12, 2022	BUY	$5.48 - $8.97 $11,623 - $19,025	2,121 Added 0.91%	234,120 $2.07 Million
Q1 2022 May 12, 2022	SELL	$6.42 - $11.39 $8,127 - $14,419	-1,266 Reduced 0.54%	231,999 $1.95 Million
Q4 2021 Feb 10, 2022	BUY	$9.97 - $20.38 $865,754 - $1.77 Million	86,836 Added 59.3%	233,265 $2.38 Million
Q3 2021 Nov 09, 2021	SELL	$14.13 - $27.85 $530,963 - $1.05 Million	-37,577 Reduced 20.42%	146,429 $2.84 Million
Q2 2021 Aug 11, 2021	BUY	$9.29 - $19.33 $1.71 Million - $3.56 Million	184,006 New	184,006 $3.23 Million

Others Institutions Holding INMB

# of Institutions

Shares Held

5.92M

Call Options Held

243K

Put Options Held

46.4K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $80.6M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account